Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Goodwill (2016 - 2018)

Historic Goodwill for Fortress Biotech (FBIO) over the last 3 years, with Q3 2018 value amounting to $18.6 million.

  • Fortress Biotech's Goodwill changed 0.0% to $18.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $18.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $18.6 million for FY2017, which is 0.0% changed from last year.
  • Per Fortress Biotech's latest filing, its Goodwill stood at $18.6 million for Q3 2018, which was down 0.0% from $18.6 million recorded in Q2 2018.
  • In the past 5 years, Fortress Biotech's Goodwill ranged from a high of $21.7 million in Q3 2016 and a low of $18.6 million during Q4 2016
  • Over the past 3 years, Fortress Biotech's median Goodwill value was $18.6 million (recorded in 2016), while the average stood at $19.0 million.
  • The largest annual percentage gain for Fortress Biotech's Goodwill in the last 5 years was 0.0% (2017), contrasted with its biggest fall of 1423.25% (2017).
  • Quarter analysis of 3 years shows Fortress Biotech's Goodwill stood at $18.6 million in 2016, then changed by 0.0% to $18.6 million in 2017, then changed by 0.0% to $18.6 million in 2018.
  • Its Goodwill stands at $18.6 million for Q3 2018, versus $18.6 million for Q2 2018 and $18.6 million for Q1 2018.